The administration of the FDC tablet with food had no influence on the relative bioavailability of linagliptin and metformin with regard to the extent of exposure as determined by AUC ( 0-72 ) ( linagliptin ) and AUC ( 0-inf ) ( metformin ) compared with FDC tablet administration while fasting .